AIRLINK 62.48 Increased By ▲ 2.05 (3.39%)
BOP 5.36 Increased By ▲ 0.01 (0.19%)
CNERGY 4.58 Decreased By ▼ -0.02 (-0.43%)
DFML 15.50 Increased By ▲ 0.66 (4.45%)
DGKC 66.40 Increased By ▲ 1.60 (2.47%)
FCCL 17.59 Increased By ▲ 0.73 (4.33%)
FFBL 27.70 Increased By ▲ 2.95 (11.92%)
FFL 9.27 Increased By ▲ 0.21 (2.32%)
GGL 10.06 Increased By ▲ 0.10 (1%)
HBL 105.70 Increased By ▲ 1.49 (1.43%)
HUBC 122.30 Increased By ▲ 4.78 (4.07%)
HUMNL 6.60 Increased By ▲ 0.06 (0.92%)
KEL 4.50 Decreased By ▼ -0.05 (-1.1%)
KOSM 4.48 Decreased By ▼ -0.09 (-1.97%)
MLCF 36.20 Increased By ▲ 0.79 (2.23%)
OGDC 122.92 Increased By ▲ 0.53 (0.43%)
PAEL 23.00 Increased By ▲ 1.09 (4.97%)
PIAA 29.34 Increased By ▲ 2.05 (7.51%)
PIBTL 5.80 Decreased By ▼ -0.14 (-2.36%)
PPL 107.50 Increased By ▲ 0.13 (0.12%)
PRL 27.25 Increased By ▲ 0.74 (2.79%)
PTC 18.07 Increased By ▲ 1.97 (12.24%)
SEARL 53.00 Decreased By ▼ -0.63 (-1.17%)
SNGP 63.21 Increased By ▲ 2.01 (3.28%)
SSGC 10.80 Increased By ▲ 0.05 (0.47%)
TELE 9.20 Increased By ▲ 0.71 (8.36%)
TPLP 11.44 Increased By ▲ 0.86 (8.13%)
TRG 70.86 Increased By ▲ 0.95 (1.36%)
UNITY 23.62 Increased By ▲ 0.11 (0.47%)
WTL 1.28 No Change ▼ 0.00 (0%)
BR100 6,944 Increased By 65.8 (0.96%)
BR30 22,827 Increased By 258.6 (1.15%)
KSE100 67,142 Increased By 594.3 (0.89%)
KSE30 22,090 Increased By 175.1 (0.8%)
World

Israeli court limits use of spy agency to track virus cases

  • The government began using the Shin Bet's surveillance technologies in March 2020, when Covid-19 infections began to spike.
Published March 1, 2021

JERUSALEM: Israel's top court ruled Tuesday the government must curb its use of the domestic spy agency to track coronavirus infections, saying "draconian" surveillance constituted a blow to democracy.

The government began using the Shin Bet's surveillance technologies in March 2020, when Covid-19 infections began to spike.

But the supreme court quickly blocked such practice, saying legislation was needed to authorise the programme.

Tracking was discontinued in June but the following month, amid another infection surge, parliament passed a law allowing the surveillance when "an epidemiological investigation cannot be completed otherwise".

Initially approved for three weeks, that has measure has been repeatedly extended since while details of how information was obtained were kept secret.

Critics cried foul over invasion of privacy, but supporters claimed there was no civilian alternative to the Shin Bet's technologies.

Ruling on a challenge filed by four civil society groups, a seven-judge panel said the government must significantly limit its use of the spy agency beginning March 14.

"From this day on, the use of the Shin Bet will be limited to cases in which a confirmed coronavirus patient was not cooperating in his (epidemiological) investigation, whether intentionally or not, or gave no report of his encounters," the court said.

The justices criticised the state's protracted use of the Shin Bet in the pandemic fight, saying it gave the feeling that "every Israeli citizen and resident is under constant surveillance, as if he were a character in George Orwell's '1984' (novel)."

"Allowing the government to use the surveillance details is a severe, exceptional and draconian blow to the right for privacy and the democratic fabric of society in Israel," the decision said.

The ruling noted improvements in the health ministry's epidemiological investigations.

That, combined with flaws in the Shin Bet's monitoring technology, made its use more harmful than beneficial, the court said.

The Association for Civil Rights in Israel, one of the petitioners, welcomed the ruling, which they hoped would lead authorities "to pause and change course from this slippery slope of using extreme and undemocratic means" against the pandemic.

Deputy health minister Yoav Kisch of the ruling Likud party called the decision "a crime against the health of Israeli citizens".

"To this day the Shin Bet's abilities saved the lives of 500 Israelis. On March 14 that will end because of the supreme court," he wrote on Twitter.

Comments

Comments are closed.